menu
    • menu

    Company profile for Sandoz B2B

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sandoz B2B provides access to an extensive portfolio of high-quality products and services, covering more than 20 therapeutic areas. Delivering unique added value to our partners with complete operational and technical support, we are dedicated to giving our customers the service that boosts their business.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sandoz B2BSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Forum 1, Novartis Campus, CH-4056 Basel
    Telephone
    Telephone
    +41 613241111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sandoz.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sandoz/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/sandoz_global

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI South East Asia

    Not Confirmed

    envelop Contact Supplier

    CPhI South East Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 1265

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaProviding RSMs & API to Global Pharma CompaniesProviding RSMs & API to Global Pharma Companies

    Providing RSMs & API to Global Pharma Companies
    Providing RSMs & API to Global Pharma Companies

    reelProviding RSMs & API to Global Pharma Companies

    This PharmaReel showcases Allsino Pharmaceutical, a company that provides GMP-certified RSMs and APIs to global pharma companies, specializing in peptides, oligonucleotides, and small molecule CDMO services. Allsino has a presence in the US, EU, China and Japan.

    Impressions: 1571

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    The pharmaceutical industry has witnessed a wave of mergers, acquisitions, and strategic partnerships so far in the first half (H1) of 2025, with deal values exceeding US$ 170 billion.PharmaCompass’ data shows oncology alone accounted for nearly US$ 47 billion in deal value, followed by US$ 18 billion each in immunology and psychiatry, US$ 17 billion in nutrition/weight loss and US$ 7 billion in neurology.Pharma majors such as Johnson & Johnson and Bristol Myers Squibb led with two deals worth over US$ 10 billion each. Sanofi executed a series of deals in the immunology and neuro-inflammation space. And Eli Lilly stood out for its aggressive dealmaking, which spanned oncology, pain, RNA therapies, and AI-driven oligonucleotides. In all, it signed seven deals worth over US$ 1 billion each. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available)H1 records several mega deals as J&J buys Intra-Cellular, BMS ties up with BioNTech, Sanofi acquires BlueprintJohnson & Johnson dominated headlines with its US$ 14.6 billion acquisition of Intra-Cellular Therapies in January 2025. This marks the largest biopharma deal since Novo Nordisk’s US$ 16.5 billion acquisition of Catalent in February 2024. This acquisition positions J&J as a formidable player in the neuroscience space. Bristol Myers Squibb entered into a US$ 11.1 billion partnership with BioNTech. The deal structure — US$ 3.5 billion in unconditional payments and up to US$ 7.6 billion in milestone payments — demonstrates BMS’ confidence in BNT327, a next-generation bispecific antibody in phase 3 trials for treating extensive stage small cell lung cancer and non-small cell lung cancer.Sanofi acquired Blueprint Medicines for US$ 9.5 billion in order to enhance its rare disease portfolio. The French drugmaker is also creating a comprehensive immunology portfolio. The company signed a US$ 1.9 billion deal for Dren Bio’s DR-0201 bispecific antibody for autoimmune diseases. Sanofi also acquired Vigil Neuroscience for US$ 470 million for its phase 2-ready Alzheimer’s disease candidate. Additionally, the drugmaker secured a US$ 1.84 billion global license agreement with Earendil Labs for two next-generation bispecific antibodies.Pfizer’s US$ 6.05 billion partnership with 3SBio provides it global licensing rights (excluding China) for SSGJ-707, a bispecific antibody currently undergoing multiple clinical trials in China for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Obesity gold rush sees Roche, AbbVie, Sciwind ink deals; Novo pledges over US$ 5 bn across three dealsThe obesity therapeutics market has triggered intense competition among pharmaceutical giants. Roche’s US$ 5.3 billion partnership with Zealand Pharma is focused on petrelintide, an amylin analog designed to preserve lean mass better than existing GLP-1-based treatments. The collaboration combines petrelintide with Roche’s dual GLP-1/GIP receptor agonist CT-388, creating a differentiated obesity treatment.Market leader Novo Nordisk has promised over US$ 5 billion across three major obesity deals in 2025. The US$ 2.2 billion Septerna collaboration targets oral small molecule medicines for obesity and cardiometabolic diseases.Novo signed a separate US$ 2 billion agreement with China’s United Biotechnology for UBT251, a triple agonist for GLP-1, GIP, and glucagon receptors in phase 2 clinical development for obesity, type 2 diabetes, and other diseases. The company’s third major deal, a US$ 1 billion partnership with Lexicon Pharmaceuticals, provides it access to LX9851, a molecule in preclinical development for obesity and associated metabolic disorders.Sciwind Biosciences secured a US$ 2.5 billion global licensing and collaboration agreement with Verdiva Bio Limited for the global development and commercialization of a portfolio of metabolic diseases therapies. AbbVie entered the amylin arena through its US$ 2.2 billion Gubra partnership for GUB014295, a candidate in phase 1 trials for treating obesity. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Molecular glue degraders draw investments; Lilly signs seven deals over US$ 1 billion eachMolecular glue degraders have emerged as a transformative therapeutic modality, attracting significant investment across multiple partnerships. AbbVie’s US$ 1.64 billion collaboration with Neomorph leverages the biotech’s leading molecular glue discovery platform for oncology and immunology applications.Genentech’s potential US$ 2.1 billion partnership with Orionis Biosciences focuses on small-molecule monovalent glue medicines for novel and challenging oncology targets. This is the second partnership between the two companies, following their initial 2023 collaboration.Eli Lilly has collaborated with Magnet Biomedicine, utilizing Magnet’s TrueGlue discovery platform for oncology applications. The deal could be worth up to US$ 1.3 billion.Eli Lilly has emerged as one of 2025’s most active dealmakers, with approximately seven deals exceeding US$ 1 billion each. The company’s US$ 2.5 billion Scorpion Therapeutics acquisition provides access to STX-478, an experimental oral therapy in early-stage trials for breast cancer and advanced solid tumors, potentially addressing 30 to 40 percent of hormone-positive breast cancer patients.On June 17, Lilly announced the acquisition of gene-editing startup Verve Therapeutics for US$ 1.3 billion. Lilly’s US$ 1 billion SiteOne acquisition announced in May brings STC-004, a phase 2-ready non-opioid chronic pain treatment to its pipeline. Other partnerships announced by Lilly include a US$ 1.4 billion capsid licensing deal with Sangamo for central nervous system disease genomic medicines and a US$ 1.3 billion collaboration with South Korean company Rznomics for RNA-based hearing loss treatments. Lilly has also strengthened its oligonucleotide pipeline through a potential US$ 1 billion collaboration with Creyon Bio for AI-designed oligonucleotide therapies targeting RNA. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Merck KGaA acquires SpringWorks for US$ 3.9 bn; Novartis buys out Anthos for US$ 3.1 bnAstraZeneca signed a US$ 5.3 billion AI-led research agreement with China’s CSPC Pharmaceuticals Group to advance the discovery of novel oral candidates for immunological diseases. Merck KGaA acquired SpringWorks for US$ 3.9 billion in April, which gave it access to two FDA-approved therapies — Ogsiveo (nirogacestat), the first and only approved therapy for adult patients with progressing desmoid tumors requiring systemic treatment, and Gomekli (mirdametinib), the first and only FDA-approved therapy for adults and children with neurofibromatosis type 1-associated plexiform neurofibromas.Novartis’ US$ 3.1 billion Anthos Therapeutics acquisition centered around abelacimab, a potential first-in-class monoclonal antibody currently in three phase 3 studies for stroke and systemic embolism prevention in atrial fibrillation patients.GSK’s US$ 2 billion acquisition of Boston Pharmaceuticals’ efimosfermin targets steatotic liver disease (fatty liver disease). The medicine is also in clinical development for MASH treatment. GSK’s second major deal involved the US$ 1.15 billion acquisition of US biotech IDRx, strengthening its gastrointestinal cancer portfolio.The pharma industry also drew some private equity interest as Bain Capital acquired Japan’s Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group for US$ 3.3 billion. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Our viewDespite an uncertain geopolitical environment, the year has seen a surge in M&As and dealmaking in the first half of 2025. However, a sizable chunk of the acquisitions were bolt-on transactions, indicating that companies are not ready to take on risks, and are buying out smaller players who strategically fit into their operations. Going forward, there are indications that M&A activity will stay strong throughout 2025. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 6617

    https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025

    #PharmaFlow by PHARMACOMPASS
    19 Jun 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Sandoz Pumps $440 M Into Another Slovenia Biosimilar Plant
    Sandoz Pumps $440 M Into Another Slovenia Biosimilar Plant

    03 Jul 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/sandoz-11b-spree-slovenia-earmarks-440m-new-biosimilar-plant

    FIERCE PHARMA
    03 Jul 2025
    Share Share
    Enforcement Report - Week of July 2, 2025
    Enforcement Report - Week of July 2, 2025

    02 Jul 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-2-2025-91897.pdf

    FDA
    02 Jul 2025
    Share Share
    Sandoz Issues a Nationwide Recall of Cefazolin
    Sandoz Issues a Nationwide Recall of Cefazolin

    27 Jun 2025

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sandoz-inc-issues-voluntary-nationwide-recall-one-lot-cefazolin-injection-due-product-mispackaging

    FDA
    27 Jun 2025
    Share Share
    Sandoz Launches Interchangeable Denosumab Biosimilars in US
    Sandoz Launches Interchangeable Denosumab Biosimilars in US

    02 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/02/3091537/0/en/Sandoz-launches-first-and-only-interchangeable-denosumab-biosimilars-in-US-providing-new-affordable-treatment-options-for-over-10-million-patients-1.html

    GLOBENEWSWIRE
    02 Jun 2025
    Share Share
    Sandoz launches Pyzchiva® autoinjector in Europe
    Sandoz launches Pyzchiva® autoinjector in Europe

    21 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/21/3085965/0/en/Sandoz-launches-Pyzchiva-autoinjector-first-commercially-available-in-Europe-for-ustekinumab-biosimilars.html

    GLOBENEWSWIRE
    21 May 2025
    Share Share
    Sandoz`s Generics Sugammadex Receives Tentative Approval in US
    Sandoz`s Generics Sugammadex Receives Tentative Approval in US

    20 May 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214311

    FDA
    20 May 2025
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Amoxicillin Trihydrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharmex
    Not Confirmed
    arrow

    Amoxicillin Trihydrate

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2019-08-13

    Pay. Date : 2019-08-09

    DMF Number : 13764

    Submission : 1998-09-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R2-CEP 1995-034 - Rev 06

    Issue Date : 2015-11-12

    Type : Chemical

    Substance Number : 260

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 306MF10115

    Registrant's Address : Biochemiesstrasse 10, 6250 Kundl, Austria

    Initial Date of Registration : 2024-08-22

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Lee Sung International Co., Ltd.

    Registration Date : 2024-08-23

    Registration Number : 20240823-30-A-380-25

    Manufacturer Name : Sandoz GmbH

    Manufacturer Address : Biochemiestrasse 10, 6250 Kundl, Tyrol, Austria

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Amoxicillin Trihydrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharmex
    Not Confirmed
    arrow

    Amoxicillin Trihydrate

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2023-06-23

    Pay. Date : 2023-05-22

    DMF Number : 38086

    Submission : 2023-06-02

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2023-277 - Rev 01

    Issue Date : 2024-12-17

    Type : Chemical

    Substance Number : 260

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 217MF10761

    Registrant's Address : Ctra. Granollers-Cardedeu C-251, Km 4, E-08520, Les Franqueses del Valles (Barcelona), Spain

    Initial Date of Registration : 2005-10-20

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Chong Kun Dang Co., Ltd.

    Registration Date : 2014-08-27

    Registration Number : 20050831-30-A-59-01(8)

    Manufacturer Name : Sandoz Industrial Products SA

    Manufacturer Address : Ctra. Granollers a Cardedeu Km4 E-08520 Les Franques del Barcelona,Spain

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Ampicillin Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharmex
    Not Confirmed
    arrow

    Ampicillin Sodium

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2023-04-20

    Pay. Date : 2023-04-17

    DMF Number : 13754

    Submission : 1998-09-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2024-480 - Rev 00

    Issue Date : 2025-01-20

    Type : Chemical

    Substance Number : 578

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 217MF10454

    Registrant's Address : Biochemiesstrasse 10,6250 Kundl, Austria

    Initial Date of Registration : 2005-08-24

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Lee Sung International Co., Ltd.

    Registration Date : 2021-11-05

    Registration Number : 20200603-210-J-404(1)

    Manufacturer Name : Sandoz GmbH@Sandoz Industrial Products S.A.

    Manufacturer Address : Biochemiestraβe 10 6250 Kundl Austria@Ctra. Granollers - Cardedeu C-251, km 4 08520 LES FRANQUESES DEL VALLES BARCELONA Spain

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Gentamicin Sulfate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharmex
    Not Confirmed
    arrow

    Gentamicin Sulfate

    Slovenia

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13704

    Submission : 1998-09-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2005-121 - Rev 02

    Issue Date : 2024-10-21

    Type : Chemical

    Substance Number : 331

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 220MF10041

    Registrant's Address : Verovskova ulica 57, 1526 Ljubljana, Slovenia

    Initial Date of Registration : 2008-02-05

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 48866-8256

    Start Marketing Date : 2013-07-12

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (10kg/10kg)

    Marketing Category : BULK INGREDIENT FOR ...

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Levothyroxine Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharmex
    Not Confirmed
    arrow

    Levothyroxine Sodium

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-01-15

    Pay. Date : 2012-12-21

    DMF Number : 4789

    Submission : 1983-01-06

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 1998-141 - Rev 11

    Issue Date : 2023-09-26

    Type : Chemical

    Substance Number : 401

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 217MF10456

    Registrant's Address : Biochemiesstrasse 10, 6250 Kundl, Austria

    Initial Date of Registration : 2005-08-24

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 43858-410

    Start Marketing Date : 2010-02-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (10kg/10kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Penicillin G Potassium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharmex
    Not Confirmed
    arrow

    Penicillin G Potassium

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13767

    Submission : 1998-09-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 1999-017 - Rev 05

    Issue Date : 2023-09-22

    Type : Chemical

    Substance Number : 115

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 231MF10072

    Registrant's Address : Biochemiesstrasse 10, 6250 Kundl, Austria

    Initial Date of Registration : 2019-03-12

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Cefpodoxime Proxetil

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharmex
    Not Confirmed
    arrow

    Cefpodoxime Proxetil

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16542

    Submission : 2003-04-15

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2010-283 - Rev 01

    Issue Date : 2017-12-05

    Type : Chemical

    Substance Number : 2341

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 225MF10129

    Registrant's Address : Biochemiesstrasse 10,6250 Kundl, Austria

    Initial Date of Registration : 2013-07-09

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : HKINNOEN Co., Ltd.

    Registration Date : 2014-07-25

    Registration Number : 20140611-25-A-300-07(1)

    Manufacturer Name : Sandoz GmbH

    Manufacturer Address : Biochemiestraβe 10, 6250 Kundl, Austria

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Penicillin G Potassium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharmex
    Not Confirmed
    arrow

    Penicillin G Potassium

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16847

    Submission : 2003-09-18

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2001-395 - Rev 03

    Issue Date : 2019-11-20

    Type : Chemical

    Substance Number : 113

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 229MF10169

    Registrant's Address : Biochemiesstrasse 10,6250 Kundl, Austria

    Initial Date of Registration : 2017-08-28

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Rosuvastatin Calcium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharmex
    Not Confirmed
    arrow

    Rosuvastatin Calcium

    Slovenia

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 20765

    Submission : 2007-08-09

    Status : Active

    Type : II

     CEP/COS Inactive-api
    ✖

    Certificate Number : R0-CEP 2016-321 - Rev 01

    Issue Date : 2019-04-15

    Type : Chemical

    Substance Number : 2631

    Status : Withdrawn by Holder

     JDMF arrow-down
    ✖

    Registration Number : 228MF10155

    Registrant's Address : Verovskova ulica 57, 1526 Ljubljana, Slovenia

    Initial Date of Registration : 2016-08-08

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Korea Sandoz Co., Ltd.

    Registration Date : 2021-04-06

    Registration Number : 20210406-209-J-687

    Manufacturer Name : Lek Pharmaceuticals dd

    Manufacturer Address : Kolodvorska cesta 27,1234 Menges, Slovenia

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Ampicillin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharmex
    Not Confirmed
    arrow

    Ampicillin

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharmex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13212

    Submission : 1998-04-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1999-188 - Rev 03

    Issue Date : 2018-01-15

    Type : Chemical

    Substance Number : 167

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Sandoz B2B and get a quotation

    Sandoz B2B is a supplier offers 150 products (APIs, Excipients or Intermediates).

    Find a price of Amoxicillin Trihydrate bulk with DMF, CEP, JDMF offered by Sandoz B2B

    Find a price of Ampicillin Sodium bulk with DMF, CEP, JDMF offered by Sandoz B2B

    Find a price of Levothyroxine Sodium bulk with DMF, CEP, JDMF offered by Sandoz B2B

    Find a price of Penicillin G Potassium bulk with DMF, CEP, JDMF offered by Sandoz B2B

    Find a price of Cefpodoxime Proxetil bulk with CEP, JDMF offered by Sandoz B2B

    Find a price of Penicillin G Potassium bulk with CEP, JDMF offered by Sandoz B2B

    Find a price of Amoxicillin Sodium bulk with DMF, CEP offered by Sandoz B2B

    Find a price of Ampicillin bulk with DMF, CEP offered by Sandoz B2B

    Find a price of Ampicillin Trihydrate bulk with DMF, CEP offered by Sandoz B2B

    Find a price of Benzylpenicillin Sodium bulk with DMF, CEP offered by Sandoz B2B

    Find a price of Cefazolin Sodium bulk with DMF, CEP offered by Sandoz B2B

    Find a price of Ceftazidime bulk with DMF, CEP offered by Sandoz B2B

    Find a price of Ceftriaxone bulk with DMF, CEP offered by Sandoz B2B

    Find a price of Clavulanic Acid bulk with DMF, CEP offered by Sandoz B2B

    Find a price of Cloxacillin Sodium bulk with DMF, CEP offered by Sandoz B2B

    Find a price of Penicillin G Benzathine bulk with DMF, CEP offered by Sandoz B2B

    Find a price of Penicillin G Procaine bulk with DMF, CEP offered by Sandoz B2B

    Find a price of Penicillin V Potassium bulk with DMF, CEP offered by Sandoz B2B

    Find a price of Cefixime bulk with DMF offered by Sandoz B2B

    Find a price of Cefixime bulk with CEP offered by Sandoz B2B

    Find a price of Cefotaxime bulk with DMF offered by Sandoz B2B

    Find a price of Cefpodoxime Proxetil bulk with DMF offered by Sandoz B2B

    Find a price of Clavulanic Acid bulk with DMF offered by Sandoz B2B

    Find a price of 1H-Imidazo 1 2-A Pyridin-4-Ium bulk with DMF offered by Sandoz B2B

    Find a price of 6-Aminopenicillanic Acid bulk with DMF offered by Sandoz B2B

    Find a price of 7-Amca bulk with DMF offered by Sandoz B2B

    Find a price of 7-Amino Cephalosporanic Acid bulk with DMF offered by Sandoz B2B

    Find a price of Amoxicillin Sodium bulk with CEP offered by Sandoz B2B

    Find a price of Ampicillin Sodium bulk with CEP offered by Sandoz B2B

    Find a price of Azithromycin bulk offered by Sandoz B2B

    Find a price of CAS 24280-93-1 bulk with DMF offered by Sandoz B2B

    Find a price of Cefdinir bulk with DMF offered by Sandoz B2B

    Find a price of Cefepime bulk offered by Sandoz B2B

    Find a price of Cefozopran Hydrochloride bulk with JDMF offered by Sandoz B2B

    Find a price of Ceftazidime bulk with DMF offered by Sandoz B2B

    Find a price of Cefuroxime Axetil bulk offered by Sandoz B2B

    Find a price of Cephalosporin C Sodium bulk with DMF offered by Sandoz B2B

    Find a price of Clarithromycin bulk offered by Sandoz B2B

    Find a price of Clofazimine bulk with DMF offered by Sandoz B2B

    Find a price of Erythromycin bulk offered by Sandoz B2B

    Find a price of Erythromycin Ethyl Succinate bulk offered by Sandoz B2B

    Find a price of Heparin Sodium bulk with DMF offered by Sandoz B2B

    Find a price of Imipenem bulk offered by Sandoz B2B

    Find a price of Immunomycin bulk with DMF offered by Sandoz B2B

    Find a price of Lansoprazole bulk offered by Sandoz B2B

    Find a price of Liothyronine Sodium bulk offered by Sandoz B2B

    Find a price of Omeprazole bulk offered by Sandoz B2B

    Find a price of PACA bulk with DMF offered by Sandoz B2B

    Find a price of Phenoxymethylpenicilline Benzathine Tetrahydrate bulk with CEP offered by Sandoz B2B

    Find a price of Piperacillin + Tazobactam bulk with DMF offered by Sandoz B2B

    Find a price of Piperacillin Sodium bulk with DMF offered by Sandoz B2B

    Find a price of Simvastatin bulk offered by Sandoz B2B

    Find a price of Sirolimus bulk with DMF offered by Sandoz B2B

    Find a price of Sodium Dicloxacillin bulk offered by Sandoz B2B

    Find a price of Temsirolimus bulk with DMF offered by Sandoz B2B

    Find a price of VICA CRUDE bulk with DMF offered by Sandoz B2B

    Find a price of VICA (PURE) bulk with DMF offered by Sandoz B2B

    Find a price of VICA, PURE (3-VINYL-ACA) bulk with DMF offered by Sandoz B2B

    Find a price of Amoxicillin sodium, Sterile, Enzymatic route bulk with CEP offered by Sandoz B2B

    Find a price of Amoxicillin Trihydrate bulk offered by Sandoz B2B

    Find a price of Ampicillin bulk offered by Sandoz B2B

    Find a price of Benzylpenicillin Sodium bulk offered by Sandoz B2B

    Find a price of Bopindolol bulk offered by Sandoz B2B

    Find a price of Butalbital bulk offered by Sandoz B2B

    Find a price of Cefixime bulk offered by Sandoz B2B

    Find a price of Cefotaxime bulk offered by Sandoz B2B

    Find a price of Cefprozil bulk offered by Sandoz B2B

    Find a price of Ceftriaxone bulk offered by Sandoz B2B

    Find a price of Chlorpheniramine Maleate bulk offered by Sandoz B2B

    Find a price of Chlorthalidone bulk offered by Sandoz B2B

    Find a price of Cilastatin Sodium bulk offered by Sandoz B2B

    Find a price of Cloxacillin Sodium bulk offered by Sandoz B2B

    Find a price of Clozapine bulk offered by Sandoz B2B

    Find a price of Cyclobenzaprine bulk offered by Sandoz B2B

    Find a price of Cyclosporine bulk offered by Sandoz B2B

    Find a price of Deacetyl-7-Aminocephalosporanic Acid bulk offered by Sandoz B2B

    Find a price of Dibenzsuberone bulk offered by Sandoz B2B

    Find a price of Doripenem bulk offered by Sandoz B2B

    Find a price of Escitalopram Oxalate bulk offered by Sandoz B2B

    Find a price of Esomeprazole Magnesium bulk offered by Sandoz B2B

    Find a price of Etoposide bulk offered by Sandoz B2B

    Find a price of Filgrastim bulk offered by Sandoz B2B

    Find a price of Flucloxacillin Sodium bulk offered by Sandoz B2B

    Find a price of Gabapentin bulk offered by Sandoz B2B

    Find a price of Guanfacine bulk offered by Sandoz B2B

    Find a price of L-Arginine Hydrochloride API bulk offered by Sandoz B2B

    Find a price of L-Leucine Hydrochloride bulk offered by Sandoz B2B

    Find a price of Lactic Acid bulk offered by Sandoz B2B

    Find a price of Lorazepam bulk offered by Sandoz B2B

    Find a price of Meropenem bulk offered by Sandoz B2B

    Find a price of Mycophenolic Acid bulk offered by Sandoz B2B

    Find a price of N-Butyl-6-Methylergoline-8-Carboxamide bulk offered by Sandoz B2B

    Find a price of Nafcillin bulk offered by Sandoz B2B

    Find a price of Nafcillin Sodium bulk offered by Sandoz B2B

    Find a price of NAFTIFINE HCL bulk offered by Sandoz B2B

    Find a price of Nitrofurantoin bulk offered by Sandoz B2B

    Find a price of Omeprazole Magnesium bulk offered by Sandoz B2B

    Find a price of Omeprazole Sodium bulk offered by Sandoz B2B

    Find a price of Oxacillin Sodium bulk offered by Sandoz B2B

    Find a price of Oxazepam bulk offered by Sandoz B2B

    Find a price of Oxytetracycline Hydrochloride bulk offered by Sandoz B2B

    Find a price of PACA bulk offered by Sandoz B2B

    Find a price of Pancrelipase bulk offered by Sandoz B2B

    Find a price of Pantoprazole Sodium bulk offered by Sandoz B2B

    Find a price of Penicillin G Benzathine bulk offered by Sandoz B2B

    Find a price of Pheniramine Maleate bulk offered by Sandoz B2B

    Find a price of Physostigmine Salicylate bulk offered by Sandoz B2B

    Find a price of Pyrilamine Maleate bulk offered by Sandoz B2B

    Find a price of Rabeprazole Sodium bulk offered by Sandoz B2B

    Find a price of Recombinant Human Growth Hormone bulk offered by Sandoz B2B

    Find a price of Rosiglitazone Maleate bulk offered by Sandoz B2B

    Find a price of Roxithromycin bulk offered by Sandoz B2B

    Find a price of Rs-86 Hydrobromide bulk offered by Sandoz B2B

    Find a price of Sertraline Hydrochloride bulk offered by Sandoz B2B

    Find a price of Sodium Carbonate bulk offered by Sandoz B2B

    Find a price of Sulbactam Sodium bulk offered by Sandoz B2B

    Find a price of Sulfamethoxazole bulk offered by Sandoz B2B

    Find a price of Temazepam bulk offered by Sandoz B2B

    Find a price of Teniposide bulk offered by Sandoz B2B

    Find a price of Thiamylal bulk offered by Sandoz B2B

    Find a price of Thiethylperazine Maleate bulk offered by Sandoz B2B

    Find a price of Thiopental Sodium bulk offered by Sandoz B2B

    Find a price of Tiamulin Fumarate bulk offered by Sandoz B2B

    Find a price of Tizanidine Hydrochloride bulk offered by Sandoz B2B

    Find a price of Venlafaxine Hydrochloride bulk offered by Sandoz B2B

    Find a price of SF86-327 (E)-N-(6,6-DIMETHYL-2-HEPTEN-4-YUL)-N--METHYL-1-NAPHTHALALENE bulk offered by Sandoz B2B

    Find a price of FACILITIES AND PROCEDURES IN WHITBY, ONTARIO, CANADA. bulk offered by Sandoz B2B

    Find a price of PHENYLALANINE-METHYLAMINOCYCLOL HCL bulk offered by Sandoz B2B

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES IN BASLE, SWITZERLAND. bulk offered by Sandoz B2B

    Find a price of RS-86 CAPSULES IN 0.25 mg AND 1.0 mg (BASLE, SWITZERLAND PLANT) bulk offered by Sandoz B2B

    Find a price of ACEPAM bulk offered by Sandoz B2B

    Find a price of FACILITIES AND PROCEDURES IN NUREMBERG, GERMANY bulk offered by Sandoz B2B

    Find a price of SACA SODIUM SALT bulk offered by Sandoz B2B

    Find a price of LORAZETYL bulk offered by Sandoz B2B

    Find a price of RS-86 AMPULS 10 mg/ml AS PRODUCED IN THE BASLE, SWITZERLAND PLANT bulk offered by Sandoz B2B

    Find a price of CEFUROXIME bulk offered by Sandoz B2B

    Find a price of SDZ PSC 833 bulk offered by Sandoz B2B

    Find a price of INVESTIGATIONAL DRUGS bulk offered by Sandoz B2B

    Find a price of TDM-85-530 b bulk offered by Sandoz B2B

    Find a price of Amoxicillin Sodium bulk offered by Sandoz B2B

    Find a price of Bivalirudin bulk offered by Sandoz B2B

    Find a price of Co-amoxiclav bulk offered by Sandoz B2B

    Find a price of Doxycycline Hyclate bulk offered by Sandoz B2B

    Find a price of Gentamicin Sulfate bulk offered by Sandoz B2B

    Find a price of Levothyroxine Sodium bulk offered by Sandoz B2B

    Find a price of Paclitaxel bulk offered by Sandoz B2B

    Find a price of Penicillin G Procaine bulk offered by Sandoz B2B

    Find a price of Penicillin V bulk offered by Sandoz B2B

    Find a price of Penicillin V Benzathine bulk offered by Sandoz B2B

    Find a price of Pleuromulin bulk offered by Sandoz B2B

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search